EMA Authorised: Vildagliptin / Metformin hydrochloride Accord (metformin hydrochloride;vildagliptin) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised a fixed-dose combination of vildagliptin and metformin hydrochloride (Accord) for adults with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin/metformin hydrochloride Accord (vildagliptin and metformin hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus, Type 2. MAH: Accord Healthcare S.L.U.. Decision date: 25/07/2025